 |
인쇄하기
취소
|
Chong Kun Dang seeks overseas expansion
Chong Kun Dang Pharmaceutical is aiming to go global with rosuvastain, a member of the drug class of statins.
The company on Thursday said in its regulatory filing that its rosuvastatin patent has received the green light from the U.S. Patent and Trademark Office.
The patent relates to a novel manufacturing method of rosuvastatin, intermediate compounds and their manufacturing method of i...
The company on Thursday said in its regulatory filing that its rosuvastatin patent has received the green light from the U.S. Patent and Trademark Office.
The patent relates to a novel manufacturing method of rosuvastatin, intermediate compounds and their manufacturing method of i...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.